Your browser doesn't support javascript.
loading
Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial.
Shu, Ya-Jun; He, Jian-Feng; Pei, Rong-Juan; He, Peng; Huang, Zhu-Hang; Chen, Shao-Min; Ou, Zhi-Qiang; Deng, Jing-Long; Zeng, Pei-Yu; Zhou, Jian; Min, Yuan-Qin; Deng, Fei; Peng, Hua; Zhang, Zheng; Wang, Bo; Xu, Zhong-Hui; Guan, Wu-Xiang; Hu, Zhong-Yu; Zhang, Ji-Kai.
Afiliação
  • Shu YJ; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong 510440, China.
  • He JF; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong 511430, China.
  • Pei RJ; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
  • He P; National Institutes for Food and Drug Control, Beijing 100050, China.
  • Huang ZH; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong 510440, China.
  • Chen SM; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong 510440, China.
  • Ou ZQ; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong 510440, China.
  • Deng JL; Gaozhou Center for Disease Control and Prevention, Maoming, Guangdong 525000, China.
  • Zeng PY; Gaozhou Center for Disease Control and Prevention, Maoming, Guangdong 525000, China.
  • Zhou J; Gaozhou Center for Disease Control and Prevention, Maoming, Guangdong 525000, China.
  • Min YQ; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
  • Deng F; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
  • Peng H; Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Zhang Z; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518112, China.
  • Wang B; Livzon Bio Inc., Zhuhai, Guangdong 519045, China.
  • Xu ZH; Livzon Bio Inc., Zhuhai, Guangdong 519045, China.
  • Guan WX; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
  • Hu ZY; National Institutes for Food and Drug Control, Beijing 100050, China.
  • Zhang JK; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong 510440, China.
Chin Med J (Engl) ; 134(16): 1967-1976, 2021 07 22.
Article em En | MEDLINE | ID: mdl-34310400
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China